Industry groups are celebrating US Senate passage of the 21st Century Cures bill with an overwhelming majority, teeing up the broad-based legislation that includes a range of medtech FDA reforms, research dollars and other provisions to be signed by President Obama.
The Cures bill was approved on a 94-5 vote on Dec. 7 following passage of the same bill by the...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?